BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 20427474)

  • 1. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
    Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
    J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIF signaling stimulates translation of TNF-alpha mRNA via prolonged activation of MK2.
    Gais P; Tiedje C; Altmayr F; Gaestel M; Weighardt H; Holzmann B
    J Immunol; 2010 May; 184(10):5842-8. PubMed ID: 20375303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
    Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Ernst J; Gibbs A; Kahl J; Kessler L; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Wang Z; Larson CJ
    Eur J Pharmacol; 2010 Apr; 632(1-3):93-102. PubMed ID: 20132813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.
    Foey AD; Parry SL; Williams LM; Feldmann M; Foxwell BM; Brennan FM
    J Immunol; 1998 Jan; 160(2):920-8. PubMed ID: 9551930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
    Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
    Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
    Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
    Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages.
    Ho FM; Lai CC; Huang LJ; Kuo TC; Chao CM; Lin WW
    Br J Pharmacol; 2004 Mar; 141(6):1037-47. PubMed ID: 14980980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium salicylate inhibits macrophage TNF-alpha production and alters MAPK activation.
    Vittimberga FJ; McDade TP; Perugini RA; Callery MP
    J Surg Res; 1999 Jun; 84(2):143-9. PubMed ID: 10357911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation.
    Kwak HJ; Song JS; Heo JY; Yang SD; Nam JY; Cheon HG
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1188-95. PubMed ID: 16126838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor.
    Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC
    Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X-related protein FXR1 controls post-transcriptional suppression of lipopolysaccharide-induced tumour necrosis factor-alpha production by transforming growth factor-beta1.
    Khera TK; Dick AD; Nicholson LB
    FEBS J; 2010 Jul; 277(13):2754-65. PubMed ID: 20491901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor.
    Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Inagaki K; Kondo T; Kurita N; Suzuki M; Kanayama N; Terao T
    J Periodontal Res; 2005 Dec; 40(6):461-8. PubMed ID: 16302924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
    Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS-induced up-regulation of TGF-beta receptor 1 is associated with TNF-alpha expression in human monocyte-derived macrophages.
    Chen Y; Kam CS; Liu FQ; Liu Y; Lui VC; Lamb JR; Tam PK
    J Leukoc Biol; 2008 May; 83(5):1165-73. PubMed ID: 18252868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands.
    Thuraisingam T; Xu YZ; Moisan J; Lachance C; Garnon J; Di Marco S; Gaestel M; Radzioch D
    Mol Immunol; 2007 Jul; 44(14):3482-91. PubMed ID: 17485113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
    Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.
    Kotlyarov A; Neininger A; Schubert C; Eckert R; Birchmeier C; Volk HD; Gaestel M
    Nat Cell Biol; 1999 Jun; 1(2):94-7. PubMed ID: 10559880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.